JP2018537408A5 - - Google Patents

Download PDF

Info

Publication number
JP2018537408A5
JP2018537408A5 JP2018516713A JP2018516713A JP2018537408A5 JP 2018537408 A5 JP2018537408 A5 JP 2018537408A5 JP 2018516713 A JP2018516713 A JP 2018516713A JP 2018516713 A JP2018516713 A JP 2018516713A JP 2018537408 A5 JP2018537408 A5 JP 2018537408A5
Authority
JP
Japan
Prior art keywords
oxy
amine
amino
methyl
dimethylpentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018516713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018537408A (ja
JP6785302B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/054471 external-priority patent/WO2017059085A1/en
Publication of JP2018537408A publication Critical patent/JP2018537408A/ja
Publication of JP2018537408A5 publication Critical patent/JP2018537408A5/ja
Application granted granted Critical
Publication of JP6785302B2 publication Critical patent/JP6785302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018516713A 2015-10-01 2016-09-29 ビアリールキナーゼ阻害剤 Active JP6785302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3170/DEL/2015 2015-10-01
IN3170DE2015 2015-10-01
PCT/US2016/054471 WO2017059085A1 (en) 2015-10-01 2016-09-29 Biaryl kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2018537408A JP2018537408A (ja) 2018-12-20
JP2018537408A5 true JP2018537408A5 (cg-RX-API-DMAC7.html) 2019-11-07
JP6785302B2 JP6785302B2 (ja) 2020-11-18

Family

ID=57190217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018516713A Active JP6785302B2 (ja) 2015-10-01 2016-09-29 ビアリールキナーゼ阻害剤

Country Status (7)

Country Link
US (1) US10544120B2 (cg-RX-API-DMAC7.html)
EP (1) EP3356340B1 (cg-RX-API-DMAC7.html)
JP (1) JP6785302B2 (cg-RX-API-DMAC7.html)
KR (1) KR102704295B1 (cg-RX-API-DMAC7.html)
CN (2) CN112142655A (cg-RX-API-DMAC7.html)
ES (1) ES2765730T3 (cg-RX-API-DMAC7.html)
WO (1) WO2017059085A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20181899T1 (hr) 2014-04-02 2019-01-11 Bristol-Myers Squibb Company Biaril inhibitori kinaze
US10246469B2 (en) 2015-10-01 2019-04-02 Bristol-Myers Squibb Company Biaryl kinase inhibitors
US10544120B2 (en) 2015-10-01 2020-01-28 Bristol-Myers Squibb Company Biaryl kinase inhibitors
KR102454635B1 (ko) 2016-12-19 2022-10-17 노파르티스 아게 신규 피콜린산 유도체 및 중간체로서의 이들의 용도
CN115484951A (zh) * 2020-04-21 2022-12-16 莱西肯医药有限公司 用于治疗病毒感染的aak1抑制剂
CN111995583A (zh) * 2020-08-18 2020-11-27 上海毕得医药科技有限公司 一种1,5-二甲基嘧啶-2(1h)-酮的合成方法
WO2023284838A1 (zh) * 2021-07-15 2023-01-19 四川海思科制药有限公司 Aak1抑制剂及其用途
US12344596B2 (en) 2022-03-01 2025-07-01 Lexicon Pharmaceuticals, Inc. Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof
CA3244394A1 (en) * 2022-03-01 2023-09-07 Lexicon Pharmaceuticals, Inc. METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF AN AAK1 INHIBITOR
CN120202001A (zh) * 2022-11-10 2025-06-24 西藏海思科制药有限公司 一种含aak1抑制剂的药物组合物
CN120641406A (zh) * 2023-01-16 2025-09-12 上海海雁医药科技有限公司 杂环取代的含氮杂环衍生物、其药物组合物及应用与制备方法
KR20250167096A (ko) * 2023-04-07 2025-11-28 앨리콘 파머슈티컬 컴퍼니 리미티드 Aak1 억제제인 질소 함유 헤테로고리계 화합물
WO2025092928A1 (zh) * 2023-11-02 2025-05-08 西藏海思科制药有限公司 一种可抑制连接蛋白相关激酶1的化合物、制备及其用途
WO2025230262A1 (ko) 2024-04-29 2025-11-06 심플렉스 주식회사 신규한 헤테로아릴 유도체 및 이의 aak1 억제 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2507406A1 (en) * 2002-11-05 2004-05-21 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of jak and other protein kinases
GEP20196964B (en) * 2012-02-29 2019-04-10 Seika Pharma Co Ltd Meiji Pest control composition including novel iminopyridine derivative
EP3235499A3 (en) 2012-03-09 2018-01-17 Lexicon Pharmaceuticals, Inc. Inhibition of adaptor associated kinase 1 for the treatment of pain
US8703953B2 (en) * 2012-03-09 2014-04-22 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
US8901305B2 (en) * 2012-07-31 2014-12-02 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
JP2016509066A (ja) 2013-02-22 2016-03-24 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company アダプター関連キナーゼ1(aak1)の阻害剤としての5h−クロメノ[3,4−c]ピリジン
US10253027B2 (en) 2013-07-08 2019-04-09 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
MX2016002924A (es) 2013-09-11 2016-06-06 Squibb Bristol Myers Co Inhibidores de cinasa a base de eter arilico.
CR20160180A (es) * 2013-09-19 2016-10-03 Basf Se Compuestos heterocíclicos de n-acilimino
US20160333006A1 (en) 2014-01-29 2016-11-17 Bristol-Myers Squibb Company Aryl lacta kinase inhibitors
CA2937501A1 (en) 2014-01-31 2015-08-06 Bristol-Myers Squibb Company Quinoline-based kinase inhibitors
HRP20181899T1 (hr) * 2014-04-02 2019-01-11 Bristol-Myers Squibb Company Biaril inhibitori kinaze
US20170239249A1 (en) 2014-09-30 2017-08-24 Bristol-Myers Squibb Company Quinazoline-based kinase inhibitors
ES2740224T3 (es) 2015-04-10 2020-02-05 Bristol Myers Squibb Co 6H-isocromeno[3,4-c]piridinas y benzo[c][1,7]naftiridin-6-(5H)-onas como inhibidores de la cinasa asociada a adaptador 1 (AAK1)
US10544120B2 (en) 2015-10-01 2020-01-28 Bristol-Myers Squibb Company Biaryl kinase inhibitors
US10246469B2 (en) 2015-10-01 2019-04-02 Bristol-Myers Squibb Company Biaryl kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2018537408A5 (cg-RX-API-DMAC7.html)
JP2017511329A5 (cg-RX-API-DMAC7.html)
RU2018138050A (ru) Производные тиазолопиридина как агонисты gpr119
JP2018529731A5 (cg-RX-API-DMAC7.html)
NZ604004A (en) Pyridone and aza-pyridone compounds and methods of use
JP2012501312A5 (cg-RX-API-DMAC7.html)
JP2016522232A5 (cg-RX-API-DMAC7.html)
HRP20160635T1 (hr) Inhibitori pirimidina pde10
JP2012525395A5 (cg-RX-API-DMAC7.html)
HRP20200342T1 (hr) Derivati dihidroimidazopirazinona korisni u liječenju raka
HRP20211957T1 (hr) Analozi 1,4-disupstituiranog piridazina i postupci za liječenje stanja povezanih s nedostatkom smn
JP2008519765A5 (cg-RX-API-DMAC7.html)
JP2019534324A5 (cg-RX-API-DMAC7.html)
US10376510B2 (en) 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
JP2019526550A5 (cg-RX-API-DMAC7.html)
RU2015100942A (ru) Производное пиперидинилпиразолпиридина
JP2016523977A5 (cg-RX-API-DMAC7.html)
JP2016525076A5 (cg-RX-API-DMAC7.html)
JP2013522354A5 (cg-RX-API-DMAC7.html)
SI3183247T1 (en) Aminopyrimidinyl compounds as inhibitors of JAK
JP2019514878A5 (cg-RX-API-DMAC7.html)
JP2016530274A5 (cg-RX-API-DMAC7.html)
JP2016529292A5 (cg-RX-API-DMAC7.html)
TW202024089A (zh) 三唑并-嘧啶化合物及其用途
EP4529956A3 (en) Dosage form compositions comprising an inhibitor of bruton s tyrosine kinase